Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
Bud Light's parent company expressed confidence Thursday that its U.S. market share has stabilized after a promotion with a transgender influencer cost it sales.
Earnings kicked off into high gear as Anheuser-Busch posted results on Thursday as Apple and Amazon are set to announce their financials later in the day.
Investors weren't jolted by the downgrade because they already know the fractured state of U.S. politics, the size of the country's public debt, and the challenges it faces to pay for Social Security, Medicare and other expenses.
